{
  "name" : "_cyber.sci-hub.se_MTAuMTA4MC8xNzQzNTM5MC4yMDE2LjEyNjI5MjA=_mihalache2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Occupational exposure limits for manufactured nanomaterials, a systematic review",
    "authors" : [ "Raluca Mihalache", "Jos Verbeek", "Halshka Graczyk", "Vladimir Murashov", "Pieter van Broekhuizen" ],
    "emails" : [ "jos.verbeek@ttl.fi," ],
    "sections" : [ {
      "heading" : null,
      "text" : "Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=inan20\nDownload by: [FU Berlin] Date: 29 November 2016, At: 23:00\nNanotoxicology\nISSN: 1743-5390 (Print) 1743-5404 (Online) Journal homepage: http://www.tandfonline.com/loi/inan20\nOccupational exposure limits for manufactured nanomaterials, a systematic review\nRaluca Mihalache, Jos Verbeek, Halshka Graczyk, Vladimir Murashov & Pieter van Broekhuizen\nTo cite this article: Raluca Mihalache, Jos Verbeek, Halshka Graczyk, Vladimir Murashov & Pieter van Broekhuizen (2016): Occupational exposure limits for manufactured nanomaterials, a systematic review, Nanotoxicology, DOI: 10.1080/17435390.2016.1262920 To link to this article: http://dx.doi.org/10.1080/17435390.2016.1262920\nAccepted author version posted online: 29 Nov 2016.\nSubmit your article to this journal\nView related articles\nView Crossmark data\nOccupational exposure limits for manufactured nanomaterials,\na systematic review\nAuthors:\nRaluca Mihalache 1\nJos Verbeek 1\nHalshka Graczyk 2\nVladimir Murashov 3\nPieter van Broekhuizen 4\n1 Finnish Institute of Occupational Health, Cochrane Work Group, PO Box 310, 70701 Kuopio, Finland, correspondence to jos.verbeek@ttl.fi, tel +358 46 8108709 2 Institute for Work and Health, Lausanne, Switzerland 3 National Institute for Occupational Safety and Health, Washington DC, USA 4 IVAM, University of Amsterdam, Amsterdam, the Netherlands\nDisclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of host/employing organizations. JU ST\nA CC\nEP TE\nD\nAbstract\nBackground The toxicological properties of manufactured nanomaterials (MNMs) can be different from their bulk-material and uncertainty remains about the adverse health effects they may have on humans. Proposals for OELs have been put forward which can be useful for risk management and workers’ protection. We performed a systematic review of proposals for OELs for MNMs to better understand the extent of such proposals, as well as their derivation methods.\nMethods We searched PubMed and Embase with an extensive search string and also assessed the references in the included studies. Two authors extracted data independently.\nResults We identified 20 studies that proposed in total 56 OEL values. Of these, two proposed a generic level for all MNMs, 14 proposed a generic OEL for a category of MNMs and 40 proposed an OEL for a specific nanomaterial. For specific fibres, four studies proposed a similar value but for carbon nanotubes (CNTs) the values differed with a factor ranging from 30 to 50 and for metals with a factor from 100 to 300. The studies did not provide explanations for this variation. We found that exposure to MNMs measured at selected workplaces may exceed even the highest proposed OEL. This indicates that the application and use of OELs may be useful for exposure reduction.\nConclusion OELs can provide a valuable reference point for exposure reduction measures in workplaces. There is a need for more and better supported OELs based on a more systematic approach to OEL derivation.\nJU ST\nA CC\nEP TE\nD\nKeywords Occupational exposure limit (OEL), nanoparticles, risk assessment"
    }, {
      "heading" : "BACKGROUND",
      "text" : "Nanotechnology is an expanding field, with new manufactured nanomaterials (MNMs) and products containing these materials appearing on the market every year. There is also a growing diversity of industries in which MNMs are used such as construction, health care, energy, automobile and aerospace, chemical products, electronics and communication, cleaning and maintenance, textile, and military. This means that a growing number of workers worldwide is potentially exposed to MNMs (Kaluza S et al., 2009). Systematic reviews of exposure studies confirm that workplace exposure to nanoparticles occurs and that control measures can be improved to reduce exposure (Debia, 2016, Ding et al., 2016).\nNanoparticles can be classified into three categories. There are naturally occurring nanoparticles resulting from the nucleation of low-volatile gas-phase compounds followed by growth into small particles such as via volcanic eruptions and forest fires, via erosion. Then, there are also incidental nanoparticles generated (as by-products) of heating and combustion processes, machining and other high-energy processes, also called process-generated nanoparticles or combustion-derived nanoparticles (Donaldson et al., 2005). Finally there are man-made manufactured nanoparticles intentionally produced by industry, as defined by the European Commission (E C 2011), such as carbon nanotubes. Since different sources of nanoparticles require different approaches, in this article we focus only on the third category, i.e. MNMs in the workplace.\nMany MNMs are still given the name of their bigger chemical bulk material, but due to their extremely small size (≤100 nm), their physical and chemical properties can be different from\nJU ST\nA CC\nEP TE\nD\nthose of the ‘mother’ material of the same structure and composition (Kulinowski K and B., 2011). The International Organization for Standardization (ISO) defined bulk material as “a material of the same chemical composition as nano-objects and their agglomerates and aggregates (NOAAs), at a scale greater than the nanoscale.”\nThe toxicity of MNMs largely depends on numerous physicochemical properties, including size, shape, composition, surface characteristics, charge and solubility. While workers may be exposed to MNMs via inhalation, ingestion or dermal absorption, the inhalation pathway is the most likely to result in larger systemic doses (Oberdorster et al., 2005). Once inhaled, the mechanisms, pattern and efficiency of particle deposition in the respiratory tract remains a function of its aerodynamic diameter, shape and density. Particles with a diameter from 1 to 100 nm show a much higher fraction of deposition in the pulmonary region of the lung compared to larger particles. Of inhaled particles with various diameters, only those in the nanorange are known to systematically translocate from the lungs into the circulatory system through the air-blood tissue barrier and subsequently accumulate in secondary organs and tissues of the body (Geiser and Kreyling, 2010). Due to inherent ethical concerns, most evidence comes from rodent studies, with the most reliable data using quantitative particle biokinetics assessments, which balance the total nanoparticle fractions as measured in the rodent body and total excretion collected between application and autopsy (Geiser and Kreyling, 2010). In a study by Semmler-Behnke et al with nanosized 192Iridium, it was confirmed that nanoparticles are predominantly retained long-term within interstitial spaces of the alveolar region of the rat lung, with limited translocation toward the circulation (Semmler-Behnke et al., 2007). A series of studies of particle inhalation in rodents has shown that nanoparticle translocation into the circulation and to secondary organs remains highly dependent on the nanoparticle physicochemical properties, including size, material, surface charge and surface modifications (Kreyling et al., 2002, Semmler et al., 2004, Kreyling et al., JU ST A CC EP TE D\n2009). There is currently no evidence of the nanoparticle translocation to the circulation and to secondary organs beyond 1% of the mass-based dose (Mills et al., 2006, Wiebert et al., 2006, Kreyling et al., 2014). However, this figure is based on extrapolation from animal studies, resulting in the lack of precise information for inhaled MNM bio kinetics and longterm results in the human model. Nevertheless, while acute effects from MNM translocation to secondary organs are not likely to be considerable, it is possible that chronically exposed populations may face greater risks from cumulative, low-dose translocation processes, for example from biopersistent MNMs.\nOccupational Exposure Limits (OEL) for chemical substances have long been in use for controlling workplace exposures. In 1887, Germany was the first country to publish selected limit values that were considered occupational exposure limits, but it was only in 1977 that the term had been fully adopted by the International Labour Organization (ILO) and later, in 1981, that the World Health Organization (WHO) started to use the same term: occupational exposure limits (Schulte et al., 2010).\nISO defines OELs as a “maximum concentration of airborne contaminants deemed to be acceptable, as defined by the authority having jurisdiction” (ISO 16972:2010).\nEven though there is no generally accepted uniform definition for an OEL, there is at least agreement that they constitute a level of usually airborne exposure to an agent beyond which unacceptable health risks might occur. In this general sense, we will also use the term OEL in this article. OELs are commonly established based on the actual state of the scientific knowledge and intended for protecting against adverse health effects for workers Healthbased OELs are usually based on the estimation of a no effect level and therefore they represent an exposure level below which no adverse health effects are expected(Stouten et al., 2008). However, for genotoxic and carcinogenic substances, that have no threshold JU ST\nA CC\nEP TE\nD\nbelow which there is no detectable effect, some countries, for example the Netherlands and Germany, have developed what they call risk-based OELs (S E R 2007, B A u A 2013, Ding et al., 2014). These risk concepts define a tolerable risk level and an acceptable risk level. Germany defines a tolerable risk level with a calculated additional cancer risk of 4:1 000, meaning that statistically 4 out of 1 000 persons exposed to the substance during their working life may develop cancer, and they define an acceptable risk level with a calculated cancer risk level of 4:10 000 (until 2013) and 4:100 000 (at the latest in 2018). In the Netherlands, the levels are respectively 4:1 000 and 1:1 000 000 (new cancers per year). This means that these countries acknowledge that no safe level can be defined, that even the lowest exposures may induce an adverse effect and accept that a certain number of workers may develop cancer each year as a result of the exposure. On the other hand, countries also derive OELs that include technical and economic feasibility considerations for regulatory purposes and these are thus not entirely health or risk based and these are sometimes called administrative OELs. The naming of OELs is quite inconsistent between different national and international bodies.\nWithin the REACH framework the EU defines derived no-effect levels (DNEL) for substances with a detectable threshold for health-based effects (European Chemical Agency, 2012). For genotoxic carcinogenic substances, without a threshold effect, the EU defines derived minimal effect levels (DMEL), which is a semi-quantitative value. In the US, the American Conferences of Governmental Industrial Hygienists (ACGIH) defines threshold limit values (TLV) for health-based OELs. In their local context, these values may have a distinct and complementary meaning. The values may have been established based on what was considered to be technically feasible, or may have been calculated with the goal of preventing adverse health effects, or for limiting the potential number of health effects. JU ST\nA CC\nEP TE\nD\nThese factors make it complex to compare the values, although efforts have been made to harmonize procedures for deriving OELs (Deveau et al., 2015).\nRegardless of the difficulty of unambiguously defining OELs, they form an important tool for occupational risk management within a health context. They provide a rationale for risk assessment and control measures. Based on long-term analysis of exposures at the workplace, Creely et al. argued that regulation, including the establishment of OELs, has led to a decrease in workplace exposure to a number of hazardous chemicals (Creely et al., 2007).\nMoreover, according to common principles in behavioural theory, formulating a goal that has to be achieved is a strong driver for desirable behaviour (Locke and Latham, 2002).\nPractice shows that OELs for chemical substances in general must be regarded as being provisional, requiring regular updating to comply with growing knowledge of the hazards. Therefore, insufficient scientific evidence should not be a barrier to accept provisional OELs but in contrary asks for the operationalization of the existing knowledge and if necessary for the application of precautionary measures. In fact, international experts advocate the development of provisional OELs for MNMs (van Broekhuizen and Dorbeck-Jung, 2013, Gordon et al., 2014).\nCurrently, specific regulatory OELs for MNMs have not been established by the EU or by any national authority and it is expected that it may take a long time before OELs have been derived for all highly diverse frequently used MNMs. This is mainly due to the still existing large gaps in knowledge on particle toxicology, the high diversity of the newly developed, and used, MNMs, the uncertainties about their hazardous nature and the on-going discussions on the metrics to be used for the nano-OELs, be it mass-based or particle number based. Alternatively, generic precautionary particle number based nano reference values (NVR) for groups of nanomaterials have been proposed in some countries (I F A 2009, S E R 2012). JU ST\nA CC\nEP TE\nD\nHere the adjective ‘reference’ is used to emphasize that these values are not health-based and indicates that these values should be for risk management: as an incentive to take control measures if the NVR is exceeded (S E R 2012, van Broekhuizen and Dorbeck-Jung, 2013).\nFor a few specific nanomaterials the industry and research have advised an OEL or a DNEL. NIOSH (2011) proposed an OEL for nano-TiO2 based on toxicological data and used the US threshold limit value (TLV) for coarse TiO2 (of 1.5mg/m 3 ) as a reference. Bayer (Pauluhn, 2010), Nanocyl (Luizi, 2009) and NIOSH (National Institute for Occupational Safety and Health, 2013) proposed OELs for multiwall carbon nanotubes (MWCNTs). DNELs were calculated in an experimental study by Stone et al applying the DNEL methodology with the prescribed assessment factors to MWCNTs, fullerenes, silver (Ag) and titanium dioxide (TiO2) (Stone, 2009).\nCurrently, the World Health Organization is preparing a guideline for protecting workers from potential risks of MNMs. One of the questions is: which OEL/reference value should specific nanomaterials or groups of materials be assigned to? So far, there has been limited information on the development and use of OELs for MNMs (Schulte et al., 2010, Gordon et al., 2014). To address this problem, we conducted a systematic review of existing OELs for MNMs and analysed how these values were derived."
    }, {
      "heading" : "OBJECTIVE",
      "text" : "To develop an exhaustive list of OELs that have been proposed for MNMs, and to describe differences and similarities in the approaches by which they were derived. JU ST\nA CC\nEP TE\nD"
    }, {
      "heading" : "METHODS",
      "text" : "Inclusion criteria We based our inclusion criteria on the PICO approach, which is an acronym that specifies that eligible studies must comply with criteria for one or more of the following elements: participants (P), intervention/exposure (I/E), control (C), outcome (O), and study design (S) (Guyatt et al., 2011, Morgan et al., 2016). These criteria were defined as follows.\nStudy design: We included all proposals using an exposure limit approach or that proposed a quantitative exposure limit value for an MNM or a group of MNMs for protecting workers exposed to manufactured nanomaterials from adverse health effects. To be included, the studies also had to indicate the process by which the authors derived the OELs.\nParticipants: the OEL is a tool intended to protect workers potentially exposed to MNMs.\nIntervention/Exposure: the OEL should be formulated as a concrete exposure value for a MNM or group of MNMs and should address the MNMs’ potential for adverse health effects and it should indicate how the exposure should be measured and expressed.\nWe considered that the control (C) and outcome (O) elements were not applicable in our specific situation where we are not looking for effects of controlled studies but where we want to list a specific set of OEL proposals\nSearch methods for inclusion of studies"
    }, {
      "heading" : "Electronic searches",
      "text" : "We conducted a systematic literature search in PubMed and Embase until 15 February 2016, which was not limited to the English language. The search string contained specific search words for MNMs, such as nanomaterial and synonyms, occupational exposure limit and synonyms, and OELs. We combined both search strings with AND. (See Appendix 1 for the full search strategy)\nJU ST\nA CC\nEP TE\nD"
    }, {
      "heading" : "Searching other sources",
      "text" : "We checked the reference lists of all included studies to find additional proposals. We also asked experts involved in the development of the WHO Guidelines on protecting workers from potential risks of manufactured nanomaterials (draft, WHO 2016) or one of the systematic reviews of the WHO guideline to report any proposed OELs for MNMs that they knew of.\nAnalysis We grouped the OELs per MNM or group of MNMs and analysed per OEL which process was used to derive the OEL value. Next, we categorised the derivation processes according to Gordon 2014 (Gordon et al., 2014), which we slightly adapted as:\n- Traditional quantitative risk assessment (QRA) defined as a stepped approach that\nstarts with assessing toxicological data for substance and selecting a dose – usually a no-observed-adverse-effect-level or benchmark dose to use as a point of departure to calculate a human equivalent concentration and by applying various uncertainty and modifying factors finally arriving at an OEL.\n- Bridging or read across defined as applying hazard information of one material (nano-\nor bulk material) to predict the hazards of another material (Patlewicz et al., 2013); Oomen, 2015 #10}. Even though the methods has been advocated for bulk materials to save time, money and animals, there is no consensus on how to do this (Patlewicz et al., 2013).\n- Using environmental exposure limits for particulate matter (World Health\nOrganisation, 2005)\n- Grouping defined as an approach that groups MNMs based on a common aspect of\nthe material (Oomen et al., 2015). Even though grouping should be based on similar\nJU ST\nA CC\nEP TE\nD\nprinciples as read-across, we believe that it is important to distinguish grouping from read-across for one material because of its practical consequences.\nData collection Two authors (RM, JV) independently extracted the following data per proposal into an Excel sheet: MNM, value(s), measurement metric(s), approach (how were the OELs derived), year of development, country, category of development, key study.\nRisk of bias assessment We did not try to assess the risk of bias in the development process since there are no generally accepted methods to derive OELs."
    }, {
      "heading" : "RESULTS",
      "text" : ""
    }, {
      "heading" : "Results of the searches",
      "text" : "Our systematic searches resulted in 498 references. The search in MEDLINE/PubMed resulted in 259 references and the search in Embase in 239, altogether 498 references. In addition, we located 23 potential references from other sources. After removing the duplicates this resulted in 397 references that we screened for inclusion based on title and abstract. This resulted in 73 references that we checked for inclusion based on full text assessment. After the exclusion of those (n = 49) that did not meet our inclusion criteria, we included 24 articles. To prevent double counting of studies, we aggregated articles that described the same values into one study. For example, we aggregated van Broekhuizen 2011, 2012, 2013 and the German Institute of Occupational Safety and Health (IFA) 2016 into one study van Broekhuizen 2012 because IFA 2016 explicitly referred to van Broekhuizen as the source of their values (van Broekhuizen and Reijnders, 2011, van Broekhuizen et al., 2012, van Broekhuizen and Dorbeck-Jung, 2013, Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung, 2016). This finally resulted in JU ST A CC\nEP TE\nD\nthe inclusion of 20 studies. Some groups updated their proposals for OELs over time. In this case, we only included the most recent reported value. Many studies included more than one proposal and this resulted in 56 proposals for OELs. See the flow diagram (Figure 1). We have attached also a comprehensive list with all the full text articles that have been screened and included (Appendix 2)."
    }, {
      "heading" : "Description of included studies",
      "text" : "See Table 1 for a description of included studies."
    }, {
      "heading" : "Nanomaterials addressed",
      "text" : "Studies with a general approach We found two studies that took a generic approach and proposed an OEL for all MNMs. In one study, the OEL was based on environmental exposure limits for particulate matter (PMx) (Guidotti, 2010). In the other study, the OEL was based on the number of times the potential MNM exposure concentration exceeded the local background level (McGarry et al., 2013).\nStudies with a categorical approach We found six studies that used a categorical approach when they derived an OEL for a group of nanomaterials (British Standards Institution, 2007, Pauluhn, 2011, Kuempel et al., 2012, van Broekhuizen et al., 2012, German Hazardous Substances Committee, 2013, StockmannJuvala et al., 2014). Groups were: fibres, granular biopersistent particles (GBP), MNMs with bulk material classified as CMAR-chemicals (carcinogenic, mutagenic, asthmagenic, reproductive risk), MNMs that are soluble, and MNMs that are non-biopersistent.\nStudies with a MNM specific approach Most studies evaluated specific MNMs. There were seven that evaluated TiO2 (Kuempel et al., 2006, Aschberger et al., 2011, National Institute for Occupational Safety and Health, 2011, Ogura et al., 2011, Warheit, 2013, Stockmann-Juvala et al., 2014, ŚwidwińskaGajewska and Czerczak, 2014), six that evaluated carbon nanotubes (Luizi, 2009, Stone, 2009, Pauluhn, 2010, Aschberger et al., 2011, National Institute for Occupational Safety and\nJU ST\nA CC\nEP TE\nD\nHealth, 2013, Nakanishi et al., 2015), three evaluated fullerene (Stone, 2009, Aschberger et al., 2010, Shinohara et al., 2011), three evaluated nanosilver (Stone, 2009, Aschberger et al., 2011, Swidwinska-Gajewska and Czerczak, 2015), and one study evaluated amorphous SiO2, low-toxicity dust, nanocellulose and nanoclays (Stockmann-Juvala et al., 2014)."
    }, {
      "heading" : "Routes of exposure",
      "text" : "All proposals addressed chronic inhalation exposure of the workers. One study also evaluated dermal and oral exposure to carbon nanotubes and fullerene (Stone, 2009). Stone 2009 and Aschberger 2010 also derived OEL values for short-term (15 minutes) inhalation exposure of the workers (Stone, 2009, Aschberger et al., 2010).\nThere were 15 studies which used traditional quantitative risk assessment (QRA) (Kuempel et al., 2006, Luizi, 2009, Stone, 2009, Aschberger et al., 2010, Pauluhn, 2010, Aschberger et al., 2011, National Institute for Occupational Safety and Health, 2011, Ogura et al., 2011, Shinohara et al., 2011, National Institute for Occupational Safety and Health, 2013, Warheit, 2013, Stockmann-Juvala et al., 2014, Świdwińska-Gajewska and Czerczak, 2014, Nakanishi et al., 2015, Swidwinska-Gajewska and Czerczak, 2015). There were all together six studies that used bridging or read across from short-term in vivo studies as follows. Three studies adjusted OELs that exist for the larger counterpart bulk material (British Standards Institution, 2007, van Broekhuizen et al., 2012, Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung, 2016); four studies used a bridging and a grouping approach (British Standards Institution, 2007, van Broekhuizen et al., 2012, German Hazardous Substances Committee, 2013, Stockmann-Juvala et al., 2014); three studies used only a bridging approach (British Standards Institution, 2007, van Broekhuizen et al., 2012, Stockmann-Juvala et al., 2014); two used only a grouping approach (van Broekhuizen et al., 2012, German Hazardous Substances Committee, 2013). Then there were two studies that used environmental exposure limits for particulate matter (Guidotti, 2010, McGarry et al., JU ST AC CE PT ED\n2013), and one study that used both a categorical QRA and a grouping approach based on common aspects of MNMs (Pauluhn, 2011).\nNone of the studies was based on read across from in-vitro studies.\nGeographical location and research groups The included proposals were performed by a limited number of research groups. There were three studies funded by the EU: the ENHRES programme (Engineered Nanoparticles: Review of Health and Environmental Safety) (Stone, 2009, Aschberger et al., 2011) and the Scaffold programme (Stockmann-Juvala et al., 2014). There were ten studies conducted by national occupational health or technological research institutes. One study from the United Kingdom by the British Standards Institution (British Standards Institution, 2007), three studies from NIOSH in the United States (Kuempel et al., 2006, National Institute for Occupational Safety and Health, 2011, National Institute for Occupational Safety and Health, 2013), one from BAuA in Germany (German Hazardous Substances Committee, 2013), three from NEDO in Japan (Ogura et al., 2011, Shinohara et al., 2011, Nakanishi et al., 2015), and two from Poland (Świdwińska-Gajewska and Czerczak, 2014, Swidwinska-Gajewska and Czerczak, 2015). There were two studies from universities, one from the Netherlands (van Broekhuizen et al., 2012) and the second one from Australia (McGarry et al., 2013). There were four studies by the chemical companies: Bayer (Pauluhn, 2010, Pauluhn, 2011), BASF/Nanocyl (Luizi, 2009), and DuPont (Warheit, 2013). There was also one proposal by an individual editor of a journal in Canada (Guidotti, 2010)."
    }, {
      "heading" : "Terminology used",
      "text" : "Five research groups used the term occupational exposure limit (OEL) (Pauluhn, 2010, German Hazardous Substances Committee, 2013, Warheit, 2013, Stockmann-Juvala et al., 2014, Nakanishi et al., 2015). For one group this term had a regulatory meaning (German\nJU ST\nA CC\nEP TE\nD\nHazardous Substances Committee, 2013) but not for the rest (Pauluhn, 2010, Warheit, 2013, Stockmann-Juvala et al., 2014, Nakanishi et al., 2015).\nThe four proposals by the Japanese research groups also used the term OEL but with a suffix indicating subchronic exposure spanning over 15 years called OEL period-limited or OEL PL (Ogura et al., 2011, Shinohara et al., 2011, Nakanishi et al., 2015).\nThere were two related groups which used the same data from the ENRHES 2009 project, but used different terms for the OELs. Both Stone et al. and Aschberger et al. applied the methodology as described in the appendix of the European Chemical Agency, REACH project, for deriving DNELs (European Chemical Agency, 2012, Tynkkynen et al., 2015), Aschberger and colleagues used an indicative no effect level (INEL), while Stone et al. used a derived no effect level (DNEL) (Stone, 2009, Aschberger et al., 2010, Aschberger et al., 2011). The reason for this was that the authors want to highlight that the derived INEL values should not be considered as having the same regulatory status as the DNEL values.\nVan Broekhuizen proposed a nano reference value (NRV) with a provisional status, not a regulatory one (van Broekhuizen et al., 2012).\nTwo studies by NIOSH used a recommended exposure limit (REL) which is a term used by NIOSH to describe an OEL, as the Occupational Health and Safety Administration (OSHA) uses permissible exposure limits (PELs) which are mandatory according to regulation (National Institute for Occupational Safety and Health, 2011, National Institute for Occupational Safety and Health, 2013).\nThe British Standards Institution (BSI) used the term benchmark exposure level (BEL), which indicates fairly well that this is not a health-based recommendation but a tool to help in assessing the need for control measures (British Standards Institution, 2007).\nJU ST\nA CC\nEP TE\nD\nOne study used a no effect concentration in air, which is an unusual term that was directly based on the findings of an animal exposure study carried out by the same research group (Luizi, 2009).\nOne study used particle control values (PCVs), which they defined as a concentration that exceeds three times the local back ground particle concentration in the air. For this concentration value, emission or exposure controls may need to be implemented or modified, or further assessment of the controls be undertaken (McGarry et al., 2013).\nTwo Polish studies used a maximum admissible concentration-time weighted average (MAC-TWA) (Świdwińska-Gajewska and Czerczak, 2014, Swidwinska-Gajewska and Czerczak, 2015), which is defined as the time-weighted average concentration for a conventional 8-hour workday and a work week, to which workers may be exposed during their whole working life, without any adverse effects on their health.\nOne study used benchmark occupational exposure level (Guidotti, 2010). This proposal was derived using an environmental approach, and the author suggested this term so that it should not be confused with an OEL.\nKuempel at al. used a benchmark dose approach and determined and extrapolated the values belonging to the lower limit of the 95% confidence interval of the dose that caused a 0.1 % excess risk of lung cancer in rats (BMDL) (Kuempel et al., 2006). They did not use the term OEL and discussed the derived OEL only as a human equivalent exposure estimate."
    }, {
      "heading" : "Exposure metrics used",
      "text" : "The majority of OELs are only expressed as mass concentration (µg/m 3 ). There are, however, some exceptions. There is one proposal expressed in particle concentration (either fibers/cm 3 or particle/ml) for each of the following: MNM (McGarry et al., 2013), fibers (British Standards Institution, 2007, van Broekhuizen et al., 2012, Stockmann-Juvala et al., 2014),\nJU ST\nA CC\nEP TE\nD\nGBP for metals and metal oxides (van Broekhuizen et al., 2012), and nanocellulose (Stockmann-Juvala et al., 2014). And there are two proposals expressed in particle- and mass concentrations for GBP insoluble nanomaterials (British Standards Institution, 2007).\nFour out of 56 OEL-proposals contain a value both for mass and particle number concentration (British Standards Institution, 2007, German Hazardous Substances Committee, 2013). Only one study had proposals for mass-, particle- and surface concentration (nm 2 /cm 3 ) for nanosilver (Stone, 2009).\nFor readability and clarity, we transformed all inhalation mass concentration values that were expressed as mg/m 3 into µg/m 3 .\nProposed OELs reported in studies See Table 2 for OEL values reported in the included studies.\nOELs with a general approach McGarry proposes a particle concentration of three times the local back-ground particle concentration (LBPC) level that indicates particle emission from the process at hand. This would also take into account ‘natural’ variation of the background level. The authors propose that control measures may need to be implemented if this level is exceeded for more than a total of 30 minutes during a workday, and/or if a single short-term measurement exceeds five times the LBPC. Guidotti proposes as the benchmark occupational exposure level value to simply use the value of 30 µg/m 3\nthat is set for particulate matter (PMx) in ambient air and as\nagreed upon for the general population in Canada (Guidotti, 2010). He argued that there are many similarities between PMx and MNMs and that if these values are deemed fit to protect the general population, this probably also protects workers."
    }, {
      "heading" : "OELs for fibres",
      "text" : "For fibres, all four included proposals used the same value, a level ten times lower than the asbestos OEL of 0.1 fibres/ml, because of the use of a safety margin of a factor 10. This\nJU ST\nA CC\nEP TE\nD\nparticular value was chosen because of the assumed physico-chemical similarities with asbestos (British Standards Institution, 2007, van Broekhuizen et al., 2012, German Hazardous Substances Committee, 2013, Stockmann-Juvala et al., 2014). Moreover, Stockmann-Juvala mentioned that this limit is \"based on the precautionary principle\"(Stockmann-Juvala et al., 2014). Similarly based on what is tolerated for asbestos exposure, the German authority considers a level that is ten times lower an acceptable level (Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, 2008, German Hazardous Substances Committee, 2013)."
    }, {
      "heading" : "OELs for Granular Biopersistent Nanoparticles (GBP)",
      "text" : "For GBPs, van Broekhuizen proposes two groups based on the classification recommended by the German Institute of Occupational Safety and Health (IFA): one category with a density higher than 6000 kg/m 3 and the second one having a lower density than this value (van Broekhuizen et al., 2012). The starting point for the number-based reference values is the calculation of the number of nanoparticles with a diameter of 100 nm that constitute a mass of 0.1 mg/m 3 . Values are defined as corrected for the background concentrations."
    }, {
      "heading" : "OELs for non-biopersistent nanoparticles",
      "text" : "Van Broekhuizen proposes the same OEL as for the bulk material in the case that the chemical is soluble or not biopersistent (van Broekhuizen et al., 2012)."
    }, {
      "heading" : "OELs for specific MNMs",
      "text" : ""
    }, {
      "heading" : "Carbonaceous material",
      "text" : "For carbon nanotubes and nanofibers, the proposed OELs differ considerably. The lowest proposed value is 0.67 µg/m 3 (Stone, 2009), which is smaller than 1 µg/m 3 recommended by NIOSH 2013 (National Institute for Occupational Safety and Health, 2013). Nakanishi proposes a value that is at least 30 times larger but that would protect only for 15 years (Nakanishi et al., 2015), while the NIOSH value is calculated based on 45-year working lifetime.\nJU ST\nA CC\nEP TE\nD\nAlso for fullerenes, the values differ by a factor of 50 with the same difference that the highest value protects only for15 years (Shinohara et al., 2011). The value proposed by Aschberger at al. 2011 is significantly lower (Aschberger et al., 2011).\nWith 120 and 240 µg/m 3 , the OEL values for carbon black (Kuempel et al., 2006) are much higher than for carbon nanotubes for which the highest value is 50 µg/m 3 (Pauluhn, 2010)."
    }, {
      "heading" : "Metals and metaloxides",
      "text" : "As for nanosilver, the differences are considerable with 0.098 µg/m 3 based on a large extrapolation factor and effects on the lungs, and 0.67 µg/m 3 based on more systemic effects (Stone, 2009, Aschberger et al., 2010, Aschberger et al., 2011). However, the Polish group proposed 100 to 15 times higher value of 10 µg/m 3 which was already considerably lower than the current value of 50 µg/m 3 (Swidwinska-Gajewska and Czerczak, 2015). The authors provide no clear justification for such high values.\nAlso for titanium dioxide there is considerable variation. Aschberger 2010 proposed 17 µg/m 3 , which is the lowest compared to the other groups. The highest limit was proposed by Warheit 2013 with 5000 µg/m 3 which is almost 300-fold higher (Warheit, 2013). Three studies proposed the same value of 300 µg/m 3 (National Institute for Occupational Safety and Health, 2011, Stockmann-Juvala et al., 2014, Świdwińska-Gajewska and Czerczak, 2014) where we assumed that two of those values were simply taken over from NIOSH, but this was not clearly stated in the papers.\nFor acute exposure to nanocarbon, only Aschberger and Stone derived values. For inhalation of fullerenes C60 the limits were identical, 44.4 µg/m 3 (Stone, 2009, Aschberger et al., 2011). For acute dermal exposure Stone set two limits: 0.414 mg/person bodyweight and 1.241 mg/person bodyweight based on different assumptions in the derivation (Stone, 2009).\nJU ST\nA CC\nEP TE\nD"
    }, {
      "heading" : "Other materials",
      "text" : "For other MNMs there are only single values available that are not proposed by other groups such as for low-toxicity dust, nanoclays, nanocellulose (Stockmann-Juvala et al., 2014), CMAR and soluble nanomaterials (British Standards Institution, 2007), and non-biopersistent nanomaterials (van Broekhuizen et al., 2012)."
    }, {
      "heading" : "DISCUSSION",
      "text" : "In total, we found 56 proposals for OELs for MNMs in 20 papers. Of these two proposed a level for all MNMs, 14 proposed OELs for a category of MNMs and 40 proposed OELs for a specific material. For fibres, four studies proposed a similar value but for CNTs the values differed with a factor of 30 to 50 and for metals with a factor of 100 to 300. We could not explain these differences.\nWhen we compare the exposure levels that have been reported in workplace exposure studies to the OEL values that we have reported here, it seems that there is ample room for a reduction of exposure in workplaces to comply with the proposed OELs. Debia et al. reported occupational exposure to carbon nanofibers (CNFs) in potential exposure situations with values ranging from not detected to 193 fibres/cm 3 for studies that measured particle number concentrations and from not detected to 1 000 µg/m 3 for studies that measured mass concentration (Debia, 2016). Most of these values exceed the proposed OELs discussed in this paper. For CNTs, there were only two exposure situations that exceeded the highest proposed OEL of 50 µg/m 3 but the lowest OEL of 0.67 µg/m 3 was exceeded in almost all situations that reported mass concentrations. For TiO2 on the other hand, all but one exposure situation was below the NIOSH recommended value of 300 µg/m 3 . For nanosilver, only two out of ten exposure situations were below the proposed OEL of 0.33 µg/m 3 based on inhalation exposure. Because these were workplaces that admitted researchers to take JU ST A CC\nEP TE\nD\nmeasurements, it is conceivable that in many other workplaces exposures will be higher. Applying and using the OELs presented here will be a helpful indication that control measures should be taken.\nThe strength of our study is that we performed a systematic search to identify developed OELs, assessed them, and listed them in a systematic way. We did not exclude studies based on language or on publication status. We believe that we have compiled a comprehensive list of all available values. The proposed values can be used as reference or benchmark values for comparison with workplace measurement and for risk management.\nOne of the limitations of our review is that we could not compare in detail the different methodologies used to derive the OELs. However, for those that used quantitative risk assessment, differences in the proposed levels can be explained by the animal studies used, how no-observed-adverse-effect level (NOAEL) were identified in the studies and which adjustment factors were used to extrapolate the results to a human exposure during an entire working life. Another limitation is that the studies did not always report sufficient information on the type of MNM studied. For example, TiO2 may have different crystal structures with different toxicological properties. From the studies it was not always clear which form of TiO2 was considered.\nSome studies indicated that the values were meant as a time-weighted average (TWA) over an eight-hour working day and a 40-hour workweek. Some advised as well how to calculate a value for a TWA-15 minute for short-term exposure, also referred to as STEL (Short Term Exposure Limit). By definition all OELs are 8 hour-TWA, unless otherwise stated. There is a similar situation with the interpretation of the OELs where some authors mentioned that the proposed values should prevent adverse effects over the time span of a 45-year working life but others only proposed this for a period of 15 years. Another limitation is that OELs assume\nJU ST\nA CC\nEP TE\nD\nthat the MNMs are measured as primary nanoparticles. However, workplace exposure studies indicate that most MNMs are present in microsized agglomerates, which may also be the case for the rodent studies (Debia, 2016). It is unclear how this would be taken into account.\nProgress in the nanotechnology field is continuously growing. In his 2006 article, Maynard presented five challenges regarding nanotechnology research that would span over the following two decades. Among the challenges the author proposed for the next decade the development of “instruments to assess exposure to manufactured nanomaterials” including at the workplace (Maynard et al., 2006). Our review is timely in this fashion, but still more research is needed regarding OELs.\nImplications for practice The OELs listed here can be used as reference or benchmark values for comparison with workplace exposure towards a better understanding of the need for control measures. For some MNM categories such as fibres, one concrete OEL was proposed by four different studies (British Standards Institution, 2007, van Broekhuizen et al., 2012, German Hazardous Substances Committee, 2013, Stockmann-Juvala et al., 2014). For other categories or specific MNMs there is a range of values proposed making it difficult to recommend one value over another. However, given current workplace exposure reports and when using the highest OEL values, this should be an incentive to lower exposures in the workplace.\nImplications for research There is a need to develop a coordinated approach among researchers and relevant stakeholders towards the harmonization of OEL derivation for nanomaterials. This will improve transparency and communication towards stakeholders. Communication will also be improved with a common terminology used by all the parties involved from academia to professionals and workers. Moreover, the recent and emerging need for nanomaterial\nJU ST\nA CC\nEP TE\nD\nexposure limits provides a unique opportunity for organizations worldwide to finally find consensus about the naming of OELs.\nCurrently, there is variation in the selection and analysis of animal studies used to underpin quantitative risk assessment. Using systematic reviews of animal studies, including systematic risk of bias assessment (Hooijmans and Ritskes-Hoitinga, 2013, Hooijmans et al., 2014), would lead to more uniform conclusions. Finally, agreement about interspecies and intraspecies adjustment factors would be needed to come to more similar conclusions and exposure values.\nRegular updating of this list will be necessary to keep up with scientific progress in both the field of (nano) particle toxicological research and in the field of OEL derivation.\nJU ST\nA CC\nEP TE\nD\nReferences\nAschberger, K., Johnston, H.J., Stone, V., Aitken, R.J., Tran, C.L., Hankin, S.M., Peters, S.A. & Christensen, F.M., 2010. Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol, 58, 455-73. Aschberger, K., Micheletti, C., Sokull-Kluttgen, B. & Christensen, F.M., 2011. Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies. Environ Int, 37, 1143-56. B a U A (Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (Federal Institute for Occupational Safety and Health)), 2013. The risk-based concept for carcinogenic substances developed by the Committee for Hazardous Substances. http://www.baua.de/en/Publications/Brochures/A85.html;jsessionid=2A2FB4860CBF1E5428 C3D8086C34A294.1_cid333. British Standards Institution, B., 2007. British Standards Nanotechnologies – Part 2 Guide to safe handling and disposal of manufactured nanomaterials. Bundesanstalt Für Arbeitsschutz Und Arbeitsmedizin, B., Federal Institute for Occupational Safety and Health 2008. Exposure-risk relationship for asbestos in BekGS 910. Creely, K.S., Cowie, H., Van Tongeren, M., Kromhout, H., Tickner, J. & Cherrie, J.W., 2007. Trends in inhalation exposure--a review of the data in the published scientific literature. Ann Occup Hyg, 51, 665-78. Debia, M., 2016. Engineered Nanoparticles' Exposure: A Systematic Review to formulate evidencebased recommendations in WHO guidelines. submitted. Deveau, M., Chen, C.P., Johanson, G., Krewski, D., Maier, A., Niven, K.J., Ripple, S., Schulte, P.A., Silk, J., Urbanus, J.H., Zalk, D.M. & Niemeier, R.W., 2015. The Global Landscape of Occupational Exposure Limits--Implementation of Harmonization Principles to Guide Limit Selection. J Occup Environ Hyg, 12 Suppl 1, S127-44. Ding, Q., Schenk, L. & Hansson, S.O., 2014. Setting Risk-Based Occupational Exposure Limits for NoThreshold Carcinogens. Human and Ecological Risk Assessment: An International Journal, 20, 1329-1344. Ding, Y., Kuhlbusch, T.A., Van Tongeren, M., Jimenez, A.S., Tuinman, I., Chen, R., Alvarez, I.L., Mikolajczyk, U., Nickel, C., Meyer, J., Kaminski, H., Wohlleben, W., Stahlmecke, B., Clavaguera, S. & Riediker, M., 2016. Airborne engineered nanomaterials in the workplace-a review of release and worker exposure during nanomaterial production and handling processes. J Hazard Mater. Donaldson, K., Tran, L., Jimenez, L.A., Duffin, R., Newby, D.E., Mills, N., Macnee, W. & Stone, V., 2005. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Particle and Fibre Toxicology, 2, 1-14. E C (European Commission), 2011. Commission Recommendation of 18 October 2011 on the definition of nanomaterial (2011/696/EU). http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:275:0038:0040:EN:PDF. European Chemical Agency, E., 2012. Guidance on information requirements and chemical safety assessment, Chapter R.8: Characterisation of dose [concentration]-response for human health. Appendix R.8-15 Use of human data in the derivation of DNEL and DMEL. Geiser, M. & Kreyling, W.G., 2010. Deposition and biokinetics of inhaled nanoparticles. Particle and Fibre Toxicology, 7, 1-17. German Hazardous Substances Committee, A., Baua, 2013. Announcement on Hazardous Substances 527 (BekGS 527) BAuA. Gordon, S.C., Butala, J.H., Carter, J.M., Elder, A., Gordon, T., Gray, G., Sayre, P.G., Schulte, P.A., Tsai, C.S. & West, J., 2014. Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials. Regul Toxicol Pharmacol, 68, 305-11. JU ST A CC EP TE D\nGuidotti, T.L., 2010. The regulation of occupational exposure to nanomaterials: a proposal. Arch Environ Occup Health, 65, 57-8. Guyatt, G.H., Oxman, A.D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., FalckYtter, Y. & Schunemann, H.J., 2011. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol, 64, 395-400. Hooijmans, C.R. & Ritskes-Hoitinga, M., 2013. Progress in using systematic reviews of animal studies to improve translational research. PLoS Med, 10, e1001482. Hooijmans, C.R., Rovers, M.M., De Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M. & Langendam, M.W., 2014. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol, 14, 43. I F A (Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung), 2009. Technical Information nanoparticles at the workplace. <http://www.dguv.de/ifa/en/fac/nanopartikel/beurteilungsmassstaebe/index.jsp>. Institut Für Arbeitsschutz Der Deutschen Gesetzlichen Unfallversicherung, I., 2016. Criteria for assessment of the effectiveness of protective measures. St Augustin. Kaluza S, Kleine Balderhaar J, Orhten B, Honnert B, E;, J., Pietrowski P, Rosell Mg, Tanarro C, T.J. & A., Z., 2009. Workplace exposures to nanoparticles. Bilbao. Kreyling, W.G., Hirn, S., Moller, W., Schleh, C., Wenk, A., Celik, G., Lipka, J., Schaffler, M., Haberl, N.,\nJohnston, B.D., Sperling, R., Schmid, G., Simon, U., Parak, W.J. & Semmler-Behnke, M., 2014. Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano, 8, 222-33.\nKreyling, W.G., Semmler-Behnke, M., Seitz, J., Scymczak, W., Wenk, A., Mayer, P., Takenaka, S. & Oberdorster, G., 2009. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol, 21 Suppl 1, 55-60. Kreyling, W.G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S. & Schulz, H., 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health, 65. Kuempel, E.D., Castranova, V., Geraci, C.L. & Schulte, P.A., 2012. Development of risk-based nanomaterial groups for occupational exposure control. J Nanopart Res, 14, 1029. Kuempel, E.D., Tran, C.L., Castranova, V. & Bailer, A.J., 2006. Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol, 18, 717-24. Kulinowski K & B., L., 2011. Training workers on the risks of nanotechnology. Locke, E.A. & Latham, G.P., 2002. Building a practically useful theory of goal setting and task motivation: A 35-year odyssey. American Psychologist, 57, 705-717. Luizi, 2009. <Luizi 2009.pdf>. Maynard, A.D., Aitken, R.J., Butz, T., Colvin, V., Donaldson, K., Oberdorster, G., Philbert, M.A., Ryan,\nJ., Seaton, A., Stone, V., Tinkle, S.S., Tran, L., Walker, N.J. & Warheit, D.B., 2006. Safe handling of nanotechnology. Nature, 444, 267-9.\nMcgarry, P., Morawska, L., Knibbs, L.D. & Morris, H., 2013. Excursion guidance criteria to guide control of peak emission and exposure to airborne engineered particles. J Occup Environ Hyg, 10, 640-51. Mills, N.L., Amin, N., Robinson, S.D., Anand, A., Davies, J., Patel, D., De La Fuente, J.M., Cassee, F.R., Boon, N.A., Macnee, W., Millar, A.M., Donaldson, K. & Newby, D.E., 2006. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med, 173. Morgan, R.L., Thayer, K.A., Bero, L., Bruce, N., Falck-Ytter, Y., Ghersi, D., Guyatt, G., Hooijmans, C., Langendam, M., Mandrioli, D., Mustafa, R.A., Rehfuess, E.A., Rooney, A.A., Shea, B., Silbergeld, E.K., Sutton, P., Wolfe, M.S., Woodruff, T.J., Verbeek, J.H., Holloway, A.C., Santesso, N. & Schunemann, H.J., 2016. GRADE: Assessing the quality of evidence in environmental and occupational health. Environ Int, 92-93, 611-6.\nJU ST\nCC\nEP TE\nD\nNakanishi, J., Morimoto, Y., Ogura, I., Kobayashi, N., Naya, M., Ema, M., Endoh, S., Shimada, M., Ogami, A., Myojyo, T., Oyabu, T., Gamo, M., Kishimoto, A., Igarashi, T. & Hanai, S., 2015. Risk Assessment of the Carbon Nanotube Group. Risk Anal, 35, 1940-56. National Institute for Occupational Safety and Health, N., 2011. <NIOSH TiO2 OEL 2011.pdf>. National Institute for Occupational Safety and Health, N., 2013. <NIOSH CNF CNT 2013.pdf>. Oberdorster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J.,\nKarn, B., Kreyling, W., Lai, D., Olin, S., Monteiro-Riviere, N., Warheit, D. & Yang, H., 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol, 2, 8.\nOgura, I., Gamo, M., Kobayashi, N., Ema, M., Adachi, K., Yamada, N. & Yamamoto, O., 2011. Risk assessment of manufactured nanomaterials, TiO2. Tsukuba, Japan. Oomen, A.G., Bleeker, E.A., Bos, P.M., Van Broekhuizen, F., Gottardo, S., Groenewold, M., Hristozov, D., Hund-Rinke, K., Irfan, M.A., Marcomini, A., Peijnenburg, W.J., Rasmussen, K., Jimenez, A.S., Scott-Fordsmand, J.J., Van Tongeren, M., Wiench, K., Wohlleben, W. & Landsiedel, R., 2015. Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials. Int J Environ Res Public Health, 12, 13415-34. Patlewicz, G., Ball, N., Booth, E.D., Hulzebos, E., Zvinavashe, E. & Hennes, C., 2013. Use of category approaches, read-across and (Q)SAR: general considerations. Regul Toxicol Pharmacol, 67, 1- 12. Pauluhn, J., 2010. Multi-walled carbon nanotubes (Baytubes): approach for derivation of occupational exposure limit. Regul Toxicol Pharmacol, 57, 78-89. Pauluhn, J., 2011. Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology, 279, 176-88. S E R ( Sociaal Economische Raad, Social and Economic Council), 2007. The Dutch OEL system as of 1 January 2007. http://www.ser.nl/en/oel_database/oel_system.aspx. S E R (Sociaal Economische Raad, Social and Economic Council), 2012. Provisional nano reference values for engineered nanomaterials. the Hague, the Netherlands. Schulte, P.A., Murashov, V., Zumwalde, R., Kuempel, E.D. & Geraci, C.L., 2010. Occupational exposure limits for nanomaterials: state of the art. Journal of Nanoparticle Research, 12, 1971-1987. Semmler-Behnke, M., Takenaka, S., Fertsch, S., Wenk, A., Seitz, J., Mayer, P., Oberdörster, G. & Kreyling, W.G., 2007. Efficient elimination of inhaled nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent reentrainment onto airways epithelia. Environ Health Perspect, 115. Semmler, M., Seitz, J., Erbe, F., Mayer, P., Heyder, J., Oberdörster, G. & Kreyling, W.G., 2004. Longterm clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol, 16. Shinohara, N., Gamo, M. & Nakanishi, J., 2011. Fullerene (C60) [online]. https://en.aistriss.jp/assessment/2721/ [Accessed Access Date Stockmann-Juvala, H., Taxell, P. & Santonen, T., 2014. Formulating occupational exposure limits values (OELs) (Inhalation & Dermal). Helsinki. Stone, V., 2009. Engineered nanoparticles: review of health and environmental safety. Edinburgh. Stouten, H., Ott, H., Bouwman, C. & Wardenbach, P., 2008. Reassessment of occupational exposure limits. Am J Ind Med, 51, 407-18. Swidwinska-Gajewska, A.M. & Czerczak, S., 2015. [Nanosilver--Occupational exposure limits]. Med Pr, 66, 429-42. Świdwińska-Gajewska, A.M. & Czerczak, S., 2014. Titanium Dioxide Nanoparticles: Occupational Exposure Limits. Medycyna Pracy. Tynkkynen, S., Santonen, T. & Stockmann-Juvala, H., 2015. A comparison of REACH-derived no-effect\nlevels for workers with EU indicative occupational exposure limit values and national limit values in Finland. Ann Occup Hyg, 59, 401-15.\nJU ST\nA CC\nEP TE\nD\nVan Broekhuizen, P. & Dorbeck-Jung, B., 2013. Exposure limit values for nanomaterials--capacity and willingness of users to apply a precautionary approach. J Occup Environ Hyg, 10, 46-53. Van Broekhuizen, P. & Reijnders, L., 2011. Building blocks for a precautionary approach to the use of nanomaterials: positions taken by trade unions and environmental NGOs in the European nanotechnologies debate. Risk Anal, 31, 1646-57. Van Broekhuizen, P., Van Veelen, W., Streekstra, W.H., Schulte, P. & Reijnders, L., 2012. Exposure limits for nanoparticles: report of an international workshop on nano reference values. Ann Occup Hyg, 56, 515-24. Warheit, D.B., 2013. How to measure hazards/risks following exposures to nanoscale or pigmentgrade titanium dioxide particles. Toxicol Lett, 220, 193-204. Wiebert, P., Sanchez-Crespo, A., Falk, R., Philipson, K., Lundin, A., Larsson, S., Möller, W., Kreyling, W.G. & Svartengren, M., 2006. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol, 18. World Health Organisation, W., 2005. WHO Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide. Geneva.\nJU ST\nA CC\nEP TE\nD\nStudy reference\nProfessional Group/Institution Funded by Country\nNanomaterial(s)\nAGS 2013 German Hazardous Substances Committee, German Federal Institute for Occupational Safety and Health (BAuA) National Institute\nGermany Granular biopersistent particles and non-entangled fibrous nanomaterials\nAschberger 2011\nENRHES project 2009\nEuropean project\nEU Carbon nanotubes (multi-walled), fullerenes, nanosilver and nano titanium dioxide\nBSI 2007\nBritish Standards Institution National Institute\nUK Fibrous nanomaterials, CMAR, insoluble and soluble nanomaterials\nGuidotti 2010\nArchives of Environmental and Occupational Health, journal Independent Canada Environmental fine particulate matter ≤ 2500nm\nKuempel 2006\nNational Institute for Occupational Safety and Health (NIOSH) National Institute\nUSA Titanium dioxide (ultrafine) and carbon black\nLuizi 2009 Nanocyl Company Belgium Carbon nanotubes McGarry 2013\nInternational Laboratory for Air Quality and Health, Queensland University of Technology University Australia Nanomaterials\nNakanishi 2015\nNew Energy and Industrial Technology Development Organization (NEDO)\nNational Institute\nJapan Carbon nanotube group: single-, double- and multi-walled nanotubes\nNIOSH 2011 National Institute for Occupational Safety and Health (NIOSH) National Institute\nUSA Titanium dioxide (ultrafine)\nNIOSH 2013 National Institute for Occupational Safety and Health (NIOSH) National Institute\nUSA Carbon nanotubes and carbon nanofibers\nOgura 2011 New Energy and Industrial Technology Development\nNational Institute\nJapan Titanium dioxide\nJU ST\nA CC\nEP TE\nD\nOrganization (NEDO)\nPauluhn 2010\nInstitute of Toxicology, Bayer Schering Pharmaceuticals Company Germany Carbon nanotubes (multi-walled)\nPauluhn 2011\nInstitute of Toxicology, Bayer Schering Pharmaceutical Company Germany Inhaled poorly soluble particles\nShinohara 2011\nNew Energy and Industrial Technology Development Organization (NEDO)\nNational Institute\nJapan Carbon fullerenes (C60)\nStockmannJuvala 2014 Scaffold SPD-7 European project\nEU Silicon dioxide (amorphous silica), titanium dioxide, carbon nanofibers, nanocellulose, nanoclays and low-toxicity dusts\nStone 2009 ENRHES project 2009\nEuropean project\nEU Carbon nanotubes, fullerenes, metals and metal oxides\nSwidwinska 2014 Nofer Institute of Occupational Medicine, Lodz National Institute\nPoland Titanium dioxide\nSwidwinska 2015 Nofer Institute of Occupational Medicine, Lodz National Institute\nPoland Nanosilver\nvan Broekhuizen 2012 IVAM, University of Amsterdam\nUniversity The Netherlands Metals and metal oxides, biopersistent granular nanomaterial\nWarheit 2013\nDuPont Company USA Titanium dioxide (nanoscale)\nTable 1: Description of studies proposing OELs included in the review (N=20)\nJU\nST\nA CC\nEP TE\nD\nCate gory Study Refere nce Nanomaterials and specifications OEL Name Mass concentratio n µg/m 3 Particle concentratio n (particle/ml, fibers/cm 3 )\nSurface concentr ation (nm 2 /cm 3 ) Approa ch\nInhalation: General Approach MN M\nGuidot ti 2010 Fine particulate matter ≤ 2500nm\nBOEL 30 Environ mental\nMN M\nMcGar ry 2013 Airborne particles from nanotechnology processes\nPCVs 3 times LBPC for over 30 minutes\nEnviron mental\nInhalation: Categorical Approach CMA R BSI 2007 CMAR nanomaterials\nBEL 0.1 x bulk WEL\nBridgin g\nFiber s AGS 2013\nNon-entangled fibrous NM\nAcceptance level (default), respirable fraction\n0.01 Bridgin g/Grou ping\nFiber s BSI 2007\nFibrous nanomaterials\nBEL 0.01 Bridgin g/Grou ping\nFiber s Stock mannJuvala 2014 Carbon nanofibers, CNFs OEL 0.01\nBridgin g/Grou ping\nFiber s van Broek huizen 2012 Carbon nanotubes, CNTs, insoluble NM with high aspect ratio ˃3:1 NRV 0.01 Bridgin g/Grou ping GBP AGS 2013\nin operations with NM: nanosized GBP with no specific toxicity\nOEL respirable fraction, default 500 Groupi ng\nGBP AGS 2013\nno specific operations with NM: granular biopersistent particles\nOEL respirable fraction 1250 Groupi ng\nGBP BSI 2007\nInsoluble nanomaterials\nBEL 0.066 x bulk WEL\n20000 Bridgin g\nGBP Pauluh n 2011 Inhaled poorly soluble particles\nDNEL 0.5 µl PMrespirable /m 3 x\nagglomerate density\nCatego rical QRA/G rouping\nGBP van Broek huizen 2012 Metals and metal oxides, biopersistent granular NM ˃6000 kg/m 3 NRV 20000 Groupi ng GBP van Broek huizen 2012 Metals and metal oxides, biopersistent granular NM ˂6000 NRV 40000 Groupi ng\nJU ST\nA CC\nEP TE\nD\nkg/m 3\nLowtoxici ty dust Stock mannJuvala 2014\nOEL 300 (respirable fraction), 4000 (inhalable fraction)\nBridgin g/Grou ping\nNon biopersi stent van Broek huizen 2012 Non-biopersistent granular NM 1-100 nm NRV applicable OEL, WEL\nBridgin g\nSolu ble\nBSI 2007\nSoluble nanomaterials\nBEL 0.5 x bulk WEL\nBridgin g\nInhalation: Specific Approach Carb on\nAschb erger 2011 Multi-walled carbon nanotubes, MWCNT 10 nm INEL 1 QRA\nCarb on Aschb erger 2011 Multi-walled carbon nanotubes, MWCNT 140 nm INEL 2 QRA Carb on Luizi 2009 Carbon nanotubes, CNTs\nNo effect concentration in air\n2.5 QRA\nCarb on Nakani shi 2015 Carbon nanotube group, SWCNT, DWCNT, MWCNT\nOEL 15 years 30 QRA\nCarb on NIOSH 2013 All carbon nanotubes and nanofibers\nREL respirable elemental carbon\n˂ 1 QRA\nCarb on Pauluh n 2010 Multi-walled carbon nanotubes, MWCNT Baytubes ® OEL, inhalable fraction 50 QRA Carb on Stone 2009\nMWCNT DNEL chronic inhalation, systemic immune effect 0.67 QRA\nCarb on Kuem pel 2006\nCarbon black, CB ultrafine\nBMDL 45 years (lung dosimetry, model 1) 120 QRA\nCarb on Kuem pel 2006\nCarbon black, CB ultrafine\nBMDL 45 years (lung dosimetry, model 2) 240 QRA\nCarb on Aschb erger 2011 Fullerenes, C60 INEL 7.4 QRA Carb on\nShinoh ara 2011 Fullerenes, C60 OEL (PL) 15 years\n390 QRA\nNano cellul ose Stock mannJuvala 2014 Nanocellulose OEL 0.01\nBridgin g\nNano clays Stock mannNanoclays OEL 300 (respirable fraction), 4000 (inhalable fraction)\nBridgin g/Grou\nJU ST\nA CC\nEP TE\nD\nJuvala 2014\nping\nNano silver Aschb erger 2011 Nano Ag INEL lung function\n0.33 QRA\nNano silver Aschb erger 2011 Nano Ag INEL lung other effects\n0.67 QRA\nNano silver Stone 2009\nNano Ag DNEL lung exposure, extrapolating factor 10\n0.098 1200 2.2 x 10 6\nQRA\nNano silver Stone 2009\nNano Ag DNEL lung exposure, extrapolating factor 3\n0.33 4000 7.2 x 10 6\nQRA\nNano silver Stone 2009\nNano Ag DNEL liver effect\n0.67 7000 1.2 x 10 7\nQRA\nNano silver Swidw inska 2015 Nano Ag MAC-TWA inhalable fraction\n10 QRA\nSilico n dioxi de Stock mannJuvala 2014 Amorphous silica, SiO2\nOEL respirable fraction 300 QRA\nTitan ium dioxi de Aschb erger 2011 TiO2 INEL 17 QRA Titan ium dioxi de Kuem pel 2006 TiO2 ultrafine BMDL 45 years (lung dosimetry, model 1) 73 QRA Titan ium dioxi de Kuem pel 2006 TiO2 ultrafine BMDL 45 years (lung dosimetry, model 2) 140 QRA Titan ium dioxi de NIOSH 2011 TiO2 ultrafine REL (up to 10 h/day, 40 h/week) 300 QRA Titan ium dioxi de Ogura 2011 TiO2 OEL (PL) 15 years 610 QRA Titan ium dioxi de Stock mannJuvala 2014 TiO2 OEL respirable fraction 100 QRA Titan ium dioxi de Swidw inska 2014 TiO2 MAC 300 QRA Titan ium dioxi Warhe it 2013 High surface reactivity anastaserutile nanoscale OEL 1000 QRA JU ST A CC\nEP TE\nD\nAGS = German Hazardous Substances Committee BEL = benchmark exposure level BMDL = benchmark dose lower (95% confidence limit of the benchmark dose, BMD)\nBOEL = benchmark occupational exposure level BSI = British Standards Institution CMAR = carcinogenic, mutagenic, asthmagenic or a reproductive toxin CNT = carbon nanotube DNEL = derived no-effect level DWCNT = double-walled carbon nanotube GBP = granular biopersistent particles INEL = indicative no effect level LBPC = local background particle concentration MAC = maximum admissible concentration MAC-TWA = maximum admissible concentration time weighted average MNM = manufactured nanomaterial MWCNT = multi-walled carbon nanotube NIOSH = National Institute for Occupational Safety and Health (United States) NM = nanomaterial NRV = nano reference value OEL = occupational exposure limit OEL (PL) = occupational exposure limit period-limited PCVs = particle control values REL = recommended exposure limit QRA = traditional quantitative risk assessment SWCNT = single-walled carbon nanotube TWA = time weighted average exposure over the 8-hour working day WEL = workplace exposure limit\nJU ST\nA CC\nEP TE\nD\nJU ST\nA CC\nEP TE\nD"
    } ],
    "references" : [ {
      "title" : "Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature",
      "author" : [ "K. Aschberger", "H.J. Johnston", "V. Stone", "R.J. Aitken", "C.L. Tran", "S.M. Hankin", "S.A. Peters" ],
      "venue" : "Regul Toxicol Pharmacol,",
      "citeRegEx" : "Aschberger et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Aschberger et al\\.",
      "year" : 2010
    }, {
      "title" : "Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies",
      "author" : [ "K. Aschberger", "C. Micheletti", "B. Sokull-Kluttgen", "F.M. Christensen" ],
      "venue" : "Environ Int,",
      "citeRegEx" : "Aschberger et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Aschberger et al\\.",
      "year" : 2011
    }, {
      "title" : "Trends in inhalation exposure--a review of the data in the published scientific literature",
      "author" : [ "K.S. Creely", "H. Cowie", "M. Van Tongeren", "H. Kromhout", "J. Tickner", "J.W. Cherrie" ],
      "venue" : "Ann Occup Hyg,",
      "citeRegEx" : "Creely et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Creely et al\\.",
      "year" : 2007
    }, {
      "title" : "Engineered Nanoparticles' Exposure: A Systematic Review to formulate evidencebased recommendations in WHO guidelines",
      "author" : [ "M. Debia" ],
      "venue" : null,
      "citeRegEx" : "Debia,? \\Q2016\\E",
      "shortCiteRegEx" : "Debia",
      "year" : 2016
    }, {
      "title" : "The Global Landscape of Occupational Exposure Limits--Implementation of Harmonization Principles to Guide Limit Selection",
      "author" : [ "M. Deveau", "C.P. Chen", "G. Johanson", "D. Krewski", "A. Maier", "K.J. Niven", "S. Ripple", "P.A. Schulte", "J. Silk", "J.H. Urbanus", "D.M. Zalk" ],
      "venue" : "J Occup Environ Hyg,",
      "citeRegEx" : "Deveau et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Deveau et al\\.",
      "year" : 2015
    }, {
      "title" : "Setting Risk-Based Occupational Exposure Limits for NoThreshold Carcinogens",
      "author" : [ "Q. Ding", "L. Schenk", "S.O. Hansson" ],
      "venue" : "Human and Ecological Risk Assessment: An International Journal,",
      "citeRegEx" : "Ding et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Ding et al\\.",
      "year" : 2014
    }, {
      "title" : "Airborne engineered nanomaterials in the workplace-a review of release and worker exposure during nanomaterial production and handling processes",
      "author" : [ "Y. Ding", "T.A. Kuhlbusch", "M. Van Tongeren", "A.S. Jimenez", "I. Tuinman", "R. Chen", "I.L. Alvarez", "U. Mikolajczyk", "C. Nickel", "J. Meyer", "H. Kaminski", "W. Wohlleben", "B. Stahlmecke", "S. Clavaguera", "M. Riediker" ],
      "venue" : "J Hazard Mater",
      "citeRegEx" : "Ding et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Ding et al\\.",
      "year" : 2016
    }, {
      "title" : "Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure",
      "author" : [ "K. Donaldson", "L. Tran", "L.A. Jimenez", "R. Duffin", "D.E. Newby", "N. Mills", "W. Macnee", "V. Stone" ],
      "venue" : "Particle and Fibre Toxicology,",
      "citeRegEx" : "Donaldson et al\\.,? \\Q2005\\E",
      "shortCiteRegEx" : "Donaldson et al\\.",
      "year" : 2005
    }, {
      "title" : "Deposition and biokinetics of inhaled nanoparticles",
      "author" : [ "M. Geiser", "W.G. Kreyling" ],
      "venue" : "Particle and Fibre Toxicology,",
      "citeRegEx" : "Geiser and Kreyling,? \\Q2010\\E",
      "shortCiteRegEx" : "Geiser and Kreyling",
      "year" : 2010
    }, {
      "title" : "Announcement on Hazardous Substances 527 (BekGS 527) BAuA",
      "author" : [ ],
      "venue" : "Baua,",
      "citeRegEx" : "Committee,? \\Q2013\\E",
      "shortCiteRegEx" : "Committee",
      "year" : 2013
    }, {
      "title" : "Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials",
      "author" : [ "S.C. Gordon", "J.H. Butala", "J.M. Carter", "A. Elder", "T. Gordon", "G. Gray", "P.G. Sayre", "P.A. Schulte", "C.S. Tsai", "J. West" ],
      "venue" : "Regul Toxicol Pharmacol,",
      "citeRegEx" : "Gordon et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Gordon et al\\.",
      "year" : 2014
    }, {
      "title" : "The regulation of occupational exposure to nanomaterials: a proposal",
      "author" : [ "T.L. Guidotti" ],
      "venue" : "Arch Environ Occup Health,",
      "citeRegEx" : "Guidotti,? \\Q2010\\E",
      "shortCiteRegEx" : "Guidotti",
      "year" : 2010
    }, {
      "title" : "GRADE guidelines: 2. Framing the question and deciding on important outcomes",
      "author" : [ "G.H. Guyatt", "A.D. Oxman", "R. Kunz", "D. Atkins", "J. Brozek", "G. Vist", "P. Alderson", "P. Glasziou", "Y. FalckYtter", "H.J. Schunemann" ],
      "venue" : "J Clin Epidemiol,",
      "citeRegEx" : "Guyatt et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Guyatt et al\\.",
      "year" : 2011
    }, {
      "title" : "Progress in using systematic reviews of animal studies to improve translational research",
      "author" : [ "C.R. Hooijmans", "M. Ritskes-Hoitinga" ],
      "venue" : "PLoS Med,",
      "citeRegEx" : "Hooijmans and Ritskes.Hoitinga,? \\Q2013\\E",
      "shortCiteRegEx" : "Hooijmans and Ritskes.Hoitinga",
      "year" : 2013
    }, {
      "title" : "SYRCLE's risk of bias tool for animal studies",
      "author" : [ "C.R. Hooijmans", "M.M. Rovers", "R.B. De Vries", "M. Leenaars", "M. Ritskes-Hoitinga", "M.W. Langendam" ],
      "venue" : "BMC Med Res Methodol,",
      "citeRegEx" : "Hooijmans et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Hooijmans et al\\.",
      "year" : 2014
    }, {
      "title" : "A (Institut für Arbeitsschutz der Deutschen",
      "author" : [ "F I" ],
      "venue" : "Gesetzlichen Unfallversicherung),",
      "citeRegEx" : "I,? \\Q2009\\E",
      "shortCiteRegEx" : "I",
      "year" : 2009
    }, {
      "title" : "Workplace exposures to nanoparticles",
      "author" : [ "Kaluza S", "Kleine Balderhaar J", "Orhten B", "Honnert B", "Pietrowski P", "Rosell Mg", "Tanarro C", "T.J", "Z. A" ],
      "venue" : null,
      "citeRegEx" : "E et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "E et al\\.",
      "year" : 2009
    }, {
      "title" : "Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size",
      "author" : [ "W.G. Kreyling", "S. Hirn", "W. Moller", "C. Schleh", "A. Wenk", "G. Celik", "J. Lipka", "M. Schaffler", "N. Haberl", "B.D. Johnston", "R. Sperling", "G. Schmid", "U. Simon", "W.J. Parak", "M. Semmler-Behnke" ],
      "venue" : "ACS Nano,",
      "citeRegEx" : "Kreyling et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Kreyling et al\\.",
      "year" : 2014
    }, {
      "title" : "Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs",
      "author" : [ "W.G. Kreyling", "M. Semmler-Behnke", "J. Seitz", "W. Scymczak", "A. Wenk", "P. Mayer", "S. Takenaka", "G. Oberdorster" ],
      "venue" : "Inhal Toxicol,",
      "citeRegEx" : "Kreyling et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Kreyling et al\\.",
      "year" : 2009
    }, {
      "title" : "Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low",
      "author" : [ "W.G. Kreyling", "M. Semmler", "F. Erbe", "P. Mayer", "S. Takenaka", "H. Schulz" ],
      "venue" : "J Toxicol Environ Health,",
      "citeRegEx" : "Kreyling et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Kreyling et al\\.",
      "year" : 2002
    }, {
      "title" : "Development of risk-based nanomaterial groups for occupational exposure control",
      "author" : [ "E.D. Kuempel", "V. Castranova", "C.L. Geraci", "P.A. Schulte" ],
      "venue" : "J Nanopart Res,",
      "citeRegEx" : "Kuempel et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Kuempel et al\\.",
      "year" : 2012
    }, {
      "title" : "Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans",
      "author" : [ "E.D. Kuempel", "C.L. Tran", "V. Castranova", "A.J. Bailer" ],
      "venue" : "Inhal Toxicol,",
      "citeRegEx" : "Kuempel et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Kuempel et al\\.",
      "year" : 2006
    }, {
      "title" : "Training workers on the risks of nanotechnology",
      "author" : [ "K B. Kulinowski" ],
      "venue" : null,
      "citeRegEx" : "Kulinowski and L.,? \\Q2011\\E",
      "shortCiteRegEx" : "Kulinowski and L.",
      "year" : 2011
    }, {
      "title" : "Building a practically useful theory of goal setting and task motivation: A 35-year odyssey",
      "author" : [ "E.A. Locke" ],
      "venue" : "American Psychologist,",
      "citeRegEx" : "Locke,? \\Q2002\\E",
      "shortCiteRegEx" : "Locke",
      "year" : 2002
    }, {
      "title" : "Excursion guidance criteria to guide control of peak emission and exposure to airborne engineered particles",
      "author" : [ "P. Mcgarry", "L. Morawska", "L.D. Knibbs", "H. Morris" ],
      "venue" : "J Occup Environ Hyg,",
      "citeRegEx" : "Mcgarry et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Mcgarry et al\\.",
      "year" : 2013
    }, {
      "title" : "Do inhaled carbon nanoparticles translocate directly into the circulation in humans",
      "author" : [ "N.L. Mills", "N. Amin", "S.D. Robinson", "A. Anand", "J. Davies", "D. Patel", "J.M. De La Fuente", "F.R. Cassee", "N.A. Boon", "W. Macnee", "A.M. Millar", "K. Donaldson", "D.E. Newby" ],
      "venue" : "Am J Respir Crit Care Med,",
      "citeRegEx" : "Mills et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Mills et al\\.",
      "year" : 2006
    }, {
      "title" : "GRADE: Assessing the quality of evidence in environmental and occupational health",
      "author" : [ "R.L. Morgan", "K.A. Thayer", "L. Bero", "N. Bruce", "Y. Falck-Ytter", "D. Ghersi", "G. Guyatt", "C. Hooijmans", "M. Langendam", "D. Mandrioli", "R.A. Mustafa", "E.A. Rehfuess", "A.A. Rooney", "B. Shea", "E.K. Silbergeld", "P. Sutton", "M.S. Wolfe", "T.J. Woodruff", "J.H. Verbeek", "A.C. Holloway", "N. Santesso", "H.J. Schunemann" ],
      "venue" : "Environ Int,",
      "citeRegEx" : "Morgan et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Morgan et al\\.",
      "year" : 2016
    }, {
      "title" : "Assessment of the Carbon Nanotube Group",
      "author" : [ "A. Maynard", "K. Donaldson", "V. Castranova", "J. Fitzpatrick", "K. Ausman", "J. Carter" ],
      "venue" : "Risk Anal,",
      "citeRegEx" : "G. et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "G. et al\\.",
      "year" : 2011
    }, {
      "title" : "nanomaterials: elements of a screening strategy",
      "author" : [ "I. Ogura", "M. Gamo", "N. Kobayashi", "M. Ema", "K. Adachi", "N. Yamada", "O. Yamamoto" ],
      "venue" : "Part Fibre Toxicol,",
      "citeRegEx" : "Ogura et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Ogura et al\\.",
      "year" : 2011
    }, {
      "title" : "Use of category",
      "author" : [ "G. Patlewicz", "N. Ball", "E.D. Booth", "E. Hulzebos", "E. Zvinavashe", "C. Hennes" ],
      "venue" : "Environ Res Public Health,",
      "citeRegEx" : "Patlewicz et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Patlewicz et al\\.",
      "year" : 2013
    }, {
      "title" : "Multi-walled carbon nanotubes (Baytubes): approach for derivation",
      "author" : [ "J. Pauluhn" ],
      "venue" : null,
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2010
    }, {
      "title" : "Efficient elimination of inhaled nanoparticles from the alveolar region",
      "author" : [ "W.G. Kreyling" ],
      "venue" : null,
      "citeRegEx" : "Kreyling,? \\Q2007\\E",
      "shortCiteRegEx" : "Kreyling",
      "year" : 2007
    }, {
      "title" : "Formulating occupational exposure",
      "author" : [ "H. Date Stockmann-Juvala", "P. Taxell", "T. Santonen" ],
      "venue" : null,
      "citeRegEx" : "Stockmann.Juvala et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Stockmann.Juvala et al\\.",
      "year" : 2014
    }, {
      "title" : "Engineered nanoparticles: review of health and environmental safety",
      "author" : [ "V. Dermal). Helsinki. Stone" ],
      "venue" : null,
      "citeRegEx" : "Stone,? \\Q2009\\E",
      "shortCiteRegEx" : "Stone",
      "year" : 2009
    }, {
      "title" : "A comparison of REACH-derived no-effect",
      "author" : [ "T. Santonen", "H. Stockmann-Juvala" ],
      "venue" : null,
      "citeRegEx" : "Tynkkynen et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Tynkkynen et al\\.",
      "year" : 2015
    }, {
      "title" : "Exposure limit values for nanomaterials--capacity and willingness of users to apply a precautionary approach",
      "author" : [ "P. Van Broekhuizen", "B. Dorbeck-Jung" ],
      "venue" : "J Occup Environ Hyg,",
      "citeRegEx" : "Broekhuizen and Dorbeck.Jung,? \\Q2013\\E",
      "shortCiteRegEx" : "Broekhuizen and Dorbeck.Jung",
      "year" : 2013
    }, {
      "title" : "Building blocks for a precautionary approach to the use of nanomaterials: positions taken by trade unions and environmental NGOs in the European nanotechnologies debate",
      "author" : [ "P. Van Broekhuizen", "L. Reijnders" ],
      "venue" : "Risk Anal,",
      "citeRegEx" : "Broekhuizen and Reijnders,? \\Q2011\\E",
      "shortCiteRegEx" : "Broekhuizen and Reijnders",
      "year" : 2011
    }, {
      "title" : "Exposure limits for nanoparticles: report of an international workshop on nano reference values",
      "author" : [ "P. Van Broekhuizen", "W. Van Veelen", "W.H. Streekstra", "P. Schulte", "L. Reijnders" ],
      "venue" : "Ann Occup Hyg,",
      "citeRegEx" : "Broekhuizen et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Broekhuizen et al\\.",
      "year" : 2012
    }, {
      "title" : "How to measure hazards/risks following exposures to nanoscale or pigmentgrade titanium dioxide particles",
      "author" : [ "D.B. Warheit" ],
      "venue" : "Toxicol Lett,",
      "citeRegEx" : "Warheit,? \\Q2013\\E",
      "shortCiteRegEx" : "Warheit",
      "year" : 2013
    }, {
      "title" : "No significant translocation of inhaled 35-nm carbon particles to the circulation in humans",
      "author" : [ "P. Wiebert", "A. Sanchez-Crespo", "R. Falk", "K. Philipson", "A. Lundin", "S. Larsson", "W. Möller", "W.G. Kreyling", "M. Svartengren" ],
      "venue" : "Inhal Toxicol,",
      "citeRegEx" : "Wiebert et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Wiebert et al\\.",
      "year" : 2006
    } ],
    "referenceMentions" : [ {
      "referenceID" : 7,
      "context" : "processes, machining and other high-energy processes, also called process-generated nanoparticles or combustion-derived nanoparticles (Donaldson et al., 2005).",
      "startOffset" : 134,
      "endOffset" : 158
    }, {
      "referenceID" : 8,
      "context" : "Of inhaled particles with various diameters, only those in the nanorange are known to systematically translocate from the lungs into the circulatory system through the air-blood tissue barrier and subsequently accumulate in secondary organs and tissues of the body (Geiser and Kreyling, 2010).",
      "startOffset" : 265,
      "endOffset" : 292
    }, {
      "referenceID" : 8,
      "context" : "rodent body and total excretion collected between application and autopsy (Geiser and Kreyling, 2010).",
      "startOffset" : 74,
      "endOffset" : 101
    }, {
      "referenceID" : 4,
      "context" : "These factors make it complex to compare the values, although efforts have been made to harmonize procedures for deriving OELs (Deveau et al., 2015).",
      "startOffset" : 127,
      "endOffset" : 148
    }, {
      "referenceID" : 2,
      "context" : "decrease in workplace exposure to a number of hazardous chemicals (Creely et al., 2007).",
      "startOffset" : 66,
      "endOffset" : 87
    }, {
      "referenceID" : 33,
      "context" : "DNELs were calculated in an experimental study by Stone et al applying the DNEL methodology with the prescribed assessment factors to MWCNTs, fullerenes, silver (Ag) and titanium dioxide (TiO2) (Stone, 2009).",
      "startOffset" : 194,
      "endOffset" : 207
    }, {
      "referenceID" : 10,
      "context" : "Next, we categorised the derivation processes according to Gordon 2014 (Gordon et al., 2014), which we slightly adapted as:",
      "startOffset" : 71,
      "endOffset" : 92
    }, {
      "referenceID" : 29,
      "context" : "- Bridging or read across defined as applying hazard information of one material (nanoor bulk material) to predict the hazards of another material (Patlewicz et al., 2013);",
      "startOffset" : 147,
      "endOffset" : 171
    }, {
      "referenceID" : 29,
      "context" : "Even though the methods has been advocated for bulk materials to save time, money and animals, there is no consensus on how to do this (Patlewicz et al., 2013).",
      "startOffset" : 135,
      "endOffset" : 159
    }, {
      "referenceID" : 11,
      "context" : "In one study, the OEL was based on environmental exposure limits for particulate matter (PMx) (Guidotti, 2010).",
      "startOffset" : 94,
      "endOffset" : 110
    }, {
      "referenceID" : 32,
      "context" : ", 2011, Swidwinska-Gajewska and Czerczak, 2015), and one study evaluated amorphous SiO2, low-toxicity dust, nanocellulose and nanoclays (Stockmann-Juvala et al., 2014).",
      "startOffset" : 136,
      "endOffset" : 167
    }, {
      "referenceID" : 33,
      "context" : "dermal and oral exposure to carbon nanotubes and fullerene (Stone, 2009).",
      "startOffset" : 59,
      "endOffset" : 72
    }, {
      "referenceID" : 32,
      "context" : ", 2011) and the Scaffold programme (Stockmann-Juvala et al., 2014).",
      "startOffset" : 35,
      "endOffset" : 66
    }, {
      "referenceID" : 38,
      "context" : "were four studies by the chemical companies: Bayer (Pauluhn, 2010, Pauluhn, 2011), BASF/Nanocyl (Luizi, 2009), and DuPont (Warheit, 2013).",
      "startOffset" : 122,
      "endOffset" : 137
    }, {
      "referenceID" : 11,
      "context" : "an individual editor of a journal in Canada (Guidotti, 2010).",
      "startOffset" : 44,
      "endOffset" : 60
    }, {
      "referenceID" : 11,
      "context" : "One study used benchmark occupational exposure level (Guidotti, 2010).",
      "startOffset" : 53,
      "endOffset" : 69
    }, {
      "referenceID" : 21,
      "context" : "1 % excess risk of lung cancer in rats (BMDL) (Kuempel et al., 2006).",
      "startOffset" : 46,
      "endOffset" : 68
    }, {
      "referenceID" : 33,
      "context" : "concentration (nm 2 /cm 3 ) for nanosilver (Stone, 2009).",
      "startOffset" : 43,
      "endOffset" : 56
    }, {
      "referenceID" : 11,
      "context" : "simply use the value of 30 μg/m 3 that is set for particulate matter (PMx) in ambient air and as agreed upon for the general population in Canada (Guidotti, 2010).",
      "startOffset" : 146,
      "endOffset" : 162
    }, {
      "referenceID" : 32,
      "context" : "Moreover, Stockmann-Juvala mentioned that this limit is \"based on the precautionary principle\"(Stockmann-Juvala et al., 2014).",
      "startOffset" : 94,
      "endOffset" : 125
    }, {
      "referenceID" : 33,
      "context" : "67 μg/m 3 (Stone, 2009), which is smaller than 1 μg/m 3 recommended by NIOSH 2013 (National Institute for Occupational Safety and Health, 2013).",
      "startOffset" : 10,
      "endOffset" : 23
    }, {
      "referenceID" : 21,
      "context" : "With 120 and 240 μg/m 3 , the OEL values for carbon black (Kuempel et al., 2006) are much higher than for carbon nanotubes for which the highest value is 50 μg/m 3 (Pauluhn, 2010).",
      "startOffset" : 58,
      "endOffset" : 80
    }, {
      "referenceID" : 38,
      "context" : "The highest limit was proposed by Warheit 2013 with 5000 μg/m 3 which is almost 300-fold higher (Warheit, 2013).",
      "startOffset" : 96,
      "endOffset" : 111
    }, {
      "referenceID" : 33,
      "context" : "mg/person bodyweight based on different assumptions in the derivation (Stone, 2009).",
      "startOffset" : 70,
      "endOffset" : 83
    }, {
      "referenceID" : 32,
      "context" : "Other materials For other MNMs there are only single values available that are not proposed by other groups such as for low-toxicity dust, nanoclays, nanocellulose (Stockmann-Juvala et al., 2014), CMAR and soluble nanomaterials (British Standards Institution, 2007), and non-biopersistent nanomaterials (van Broekhuizen et al.",
      "startOffset" : 164,
      "endOffset" : 195
    }, {
      "referenceID" : 3,
      "context" : "concentrations and from not detected to 1 000 μg/m 3 for studies that measured mass concentration (Debia, 2016).",
      "startOffset" : 98,
      "endOffset" : 111
    }, {
      "referenceID" : 3,
      "context" : "However, workplace exposure studies indicate that most MNMs are present in microsized agglomerates, which may also be the case for the rodent studies (Debia, 2016).",
      "startOffset" : 150,
      "endOffset" : 163
    } ],
    "year" : 2016,
    "abstractText" : "Background The toxicological properties of manufactured nanomaterials (MNMs) can be different from their bulk-material and uncertainty remains about the adverse health effects they may have on humans. Proposals for OELs have been put forward which can be useful for risk management and workers’ protection. We performed a systematic review of proposals for OELs for MNMs to better understand the extent of such proposals, as well as their derivation methods. Methods We searched PubMed and Embase with an extensive search string and also assessed the references in the included studies. Two authors extracted data independently. Results We identified 20 studies that proposed in total 56 OEL values. Of these, two proposed a generic level for all MNMs, 14 proposed a generic OEL for a category of MNMs and 40 proposed an OEL for a specific nanomaterial. For specific fibres, four studies proposed a similar value but for carbon nanotubes (CNTs) the values differed with a factor ranging from 30 to 50 and for metals with a factor from 100 to 300. The studies did not provide explanations for this variation. We found that exposure to MNMs measured at selected workplaces may exceed even the highest proposed OEL. This indicates that the application and use of OELs may be useful for exposure reduction.",
    "creator" : null
  }
}